Dr. Anthony John Taglienti, MD

Dr. Taglienti practices at Dermatologic Procedures of Queens County, PC in Fresh Meadows, New York.

Dr. Taglienti's NPI, 1386879880, was assigned on May 28, 2009. Dr. Taglienti graduated from Perelman School of Med at the University of Pennsylvania in 2009. Dr. Taglienti holds New York license 280332.

Dr. Taglienti's primary practice is Dermatologic Procedures of Queens County, PC, at 58-47 188th St, Fresh Meadows, NY 11365 in Queens County. The practice phone is (631) 820-4360.

Dr. Taglienti's primary practice is Dermatologic Procedures of Queens County, PC in Fresh Meadows, New York. The medical group on file is Advanced Dermatology, P.C. Dmand AI also links Dr. Taglienti to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Taglienti practices, 2 sites in all. Vendor and product names are available with a free account.

Plastic and reconstructive surgery is Dr. Taglienti's primary specialty in the NPI Registry, under taxonomy code 2086S0122X. Dmand AI has Dr. Taglienti's licenses on file in 2 states: New York and Pennsylvania.

CMS data shows 501 Medicare services from Dr. Taglienti across 13 procedure codes in 2024, for 361 Medicare patients. Medicare paid $147,309 for them. Every service was in an office.

CMS counts 361 Medicare patients who saw Dr. Taglienti in 2024. The largest group is 65 to 74, with 137 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 12% are also on Medicaid. Their average risk score is 1.18, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Taglienti's median patient age at 57, with 49% women.

In 2024, Dr. Taglienti wrote 257 Medicare Part D claims for 118 patients. 97% of them were for generic drugs. CMS names the drug for 179 of them, across 5 drugs with 11 or more claims each, at $1,583 in total drug cost. In 2023, CMS named 204 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Taglienti for performance year 2024, reported individually. Dr. Taglienti accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 51 procedures of melanoma (skin cancer) excision by Dr. Taglienti, more than 87% of the clinicians it reports for that procedure.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 5 papers to Dr. Taglienti in 2015. 2015 was the busiest year, with 2. The most frequent topics are Cosmetic Techniques and Dermal Fillers. Dr. Taglienti has published most often in Aesthet Surg J. Dr. Taglienti's most frequent co-authors are Ivona Percec, MD, PhD, Catherine S. Chang, MD and Benjamin Chang, MD.

CMS Open Payments shows 56 general payments to Dr. Taglienti from 18 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 46% of the total. Allergan Inc. paid the most, $4,257.

Dr. Taglienti graduated from Perelman School of Med at the University of Pennsylvania in 2009.